Literature DB >> 27423998

Lumbar Sympathetic Neurolysis: How to and When to Use?

Joseph J Zechlinski1, Robert A Hieb2.   

Abstract

Lumbar sympathectomy was historically a mainstay of treatment for arterial occlusive disease and other vasospastic disorders, before the development of contemporary arterial reconstructive procedures either by surgical or endovascular means. Today, percutaneous methods of sympathetic blockade are possible using chemical neurolytic or ablative modalities. Lumbar sympathetic neurolysis is generally reserved for those patients with ischemic rest pain in the setting of nonreconstructable arterial occlusive disease, although patients with complex regional pain syndrome, peripheral neuralgia, vasospastic disorders, and various other disease states such as plantar hyperhydrosis may also benefit. A working knowledge of procedural anatomy and physiology, accompanied by appropriate patient selection, serve to maximize procedural success and minimize complications, which although infrequent may cause significant morbidity. A review of technique with a focus on traditional fluoroscopy is described, with attention drawn to intraprocedural and immediate postprocedural findings, as well as discussion of expected outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ischemia; neurolysis; sympathectomy

Mesh:

Substances:

Year:  2016        PMID: 27423998     DOI: 10.1053/j.tvir.2016.04.008

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  4 in total

Review 1.  New Cancer Pain Treatment Options.

Authors:  Kenneth D Candido; Teresa M Kusper; Nebojsa Nick Knezevic
Journal:  Curr Pain Headache Rep       Date:  2017-02

2.  Lumbar sympathectomy can improve symptoms associated with ischaemia, vasculitis, diabetic neuropathy and hyperhidrosis affecting the lower extremities-a single-centre experience.

Authors:  Sean C Maguire; Christina A Fleming; Gavin O'Brien; Gerald McGreal
Journal:  Ir J Med Sci       Date:  2018-03-07       Impact factor: 1.568

3.  The Use of L2 and L3 Lumbar Sympathetic Blockade for Cancer-Related Pain, an Experience and Recommendation in the Oncologic Population.

Authors:  Matthew A Spiegel; Lee Hingula; Grant H Chen; Aron Legler; Vinay Puttanniah; Amitabh Gulati
Journal:  Pain Med       Date:  2020-01-01       Impact factor: 3.750

4.  Predictive Value of Contrast-Enhanced Ultrasound in Chemical Lumbar Sympathectomy for End-Stage Arteriosclerosis Obliterans of the Lower Extremities.

Authors:  Yue Wu; Suming Tian; Chunye Li; Weibo Zhang; Qianqian Xing; Gang Chen
Journal:  Pain Ther       Date:  2022-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.